Works matching IS 00912700 AND DT 2006 AND VI 46 AND IP 5

Results: 20

Evaluation of the drug interaction potential of aplaviroc, a novel human immunodeficiency virus entry inhibitor, using a modified cooperstown 5 + 1 cocktail.

Published in:

2006

By:

Johnson BM;
Song IH;
Adkison KK;
Borland J;
Fang L;
Lou Y;
Berrey MM;
Nafziger AN;
Piscitelli SC;
Bertino JS Jr

Publication type:

Journal Article

The effect of montelukast on nasal mucociliary clearance.

Published in:

2006

By:

Saieed WN;
Alpachachi IA;
Almashhadani WM

Publication type:

Journal Article

Absence of clinically relevant pharmacokinetic interaction between ribavirin and tenofovir in healthy subjects.

Published in:

2006

By:

Ramanathan S;
Cheng A;
Mittan A;
Ebrahimi R;
Kearney BP

Publication type:

Journal Article

Ritonavir has minimal impact on the pharmacokinetic disposition of a single dose of bupropion administered to human volunteers.

Published in:

2006

By:

Hesse LM;
Greenblatt DJ;
von Moltke LL;
Court MH

Publication type:

Journal Article

Effect of food, an antacid, and the H2 antagonist ranitidine on the absorption of BAY 59-7939 (rivaroxaban), an oral, direct factor Xa inhibitor, in healthy subjects.

Published in:

2006

By:

Kubitza D;
Becka M;
Zuehlsdorf M;
Mueck W

Publication type:

Journal Article

Development of a predictive pharmacokinetic model for a novel cyclooxygenase-2 inhibitor.

Published in:

2006

By:

Kastrissios H;
Rohatagi S;
Moberly J;
Truitt K;
Gao Y;
Wada R;
Takahashi M;
Kawabata K;
Salazar D

Publication type:

Journal Article

CYP2D6 genotype and phenotype in Amerindians of Tepehuano origin and Mestizos of Durango, Mexico.

Published in:

2006

By:

Sosa-Macías M;
Elizondo G;
Flores-Pérez C;
Flores-Pérez J;
Bradley-Alvarez F;
Alanis-Bañuelos RE;
Lares-Asseff I

Publication type:

Journal Article

Reduced methylprednisolone clearance causing prolonged pharmacodynamics in a healthy subject was not associated with CYP3A5*3 allele or a change in diet composition.

Published in:

2006

By:

Lee SJ;
Jusko WJ;
Salaita CG;
Calis KA;
Jann MW;
Spratlin VE;
Goldstein JA;
Hon YY

Publication type:

Journal Article

Pharmacokinetics of buspirone in autistic children.

Published in:

2006

By:

Edwards DJ;
Chugani DC;
Chugani HT;
Chehab J;
Malian M;
Aranda JV

Publication type:

Journal Article

Clinical evaluation of QT/QTc prolongation and proarrhythmic potential for nonantiarrhythmic drugs: the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use E14 guideline.

Published in:

2006

By:

Darpo B;
Nebout T;
Sager PT

Publication type:

Journal Article

Absence of Clinically Relevant Pharmacokinetic Interaction Between Ribavirin and Tenofovir in Healthy Subjects.

Published in:

Journal of Clinical Pharmacology, 2006, v. 46, n. 5, p. 559, doi. 10.1177/0091270006287704

By:

Ramanathan, Srinivasan;
Cheng, Andrew;
Mittan, Angelique;
Ebrahimi, Ramin;
Kearney, Brian P.

Publication type:

Article

Reduced Methylprednisolone Clearance Causing Prolonged Pharmacodynamics in a Healthy Subject Was Not Associated With CYP3A5*3 Allele or a Change in Diet Composition.

Published in:

Journal of Clinical Pharmacology, 2006, v. 46, n. 5, p. 515, doi. 10.1177/0091270006287588

By:

Lee, Su-Jun;
Jusko, William J.;
Salaita, Christine G.;
Calis, Karim A.;
Jann, Michael W.;
Spratlin, Vicky E.;
Goldstein, Joyce A.;
Hon, Yuen Yi

Publication type:

Article

The Effect of Montelukast on Nasal Mucociliary Clearance.

Published in:

Journal of Clinical Pharmacology, 2006, v. 46, n. 5, p. 588, doi. 10.1177/0091270006287587

By:

Saieed, Waffaa N.;
AlPachachi, Iman A.;
Almashhadani, Waleed M.

Publication type:

Article

CYP2D6 Genotype and Phenotype in Amerindians of Tepehuano Origin and Mestizos of Durango, Mexico.

Published in:

Journal of Clinical Pharmacology, 2006, v. 46, n. 5, p. 527, doi. 10.1177/0091270006287586

By:

Sosa-Macías, Martha;
Elizondo, Guillermo;
Flores-Pérez, Carmen;
Flores-Pérez, Janet;
Bradley-Alvarez, Francisco;
Alanis-Bañuelos, Ruth E.;
Lares-Asseff, Ismael

Publication type:

Article

Evaluation of the Drug Interaction Potential of Aplaviroc, a Novel Human Immunodeficiency Virus Entry Inhibitor, Using a Modified Cooperstown 5 + 1 Cocktail.

Published in:

Journal of Clinical Pharmacology, 2006, v. 46, n. 5, p. 577, doi. 10.1177/0091270006287291

By:

Johnson, Brendan M.;
Song, Ivy H.;
Adkison, Kimberly K.;
Borland, Julie;
Fang, Lei;
Lou, Yu;
Berrey, M. Michelle;
Nafziger, Anne N.;
Piscitelli, Stephen C.;
Bertino, Joseph S.

Publication type:

Article

Development of a Predictive Pharmacokinetic Model for a Novel Cyclooxygenase-2 Inhibitor.

Published in:

Journal of Clinical Pharmacology, 2006, v. 46, n. 5, p. 537, doi. 10.1177/0091270006287122

By:

Kastrissios, H.;
Rohatagi, S.;
Moberly, J.;
Truitt, K.;
Gao, Y.;
Wada, R.;
Takahashi, M.;
Kawabata, K.;
Salazar, D.

Publication type:

Article

Ritonavir Has Minimal Impact on the Pharmacokinetic Disposition of a Single Dose of Bupropion Administered to Human Volunteers.

Published in:

Journal of Clinical Pharmacology, 2006, v. 46, n. 5, p. 567, doi. 10.1177/0091270006286981

By:

Hesse, Leah M.;
Greenblatt, David J.;
von Moltke, Lisa L.;
Court, Michael H.

Publication type:

Article

Effect of Food, an Antacid, and the H2 Antagonist Ranitidine on the Absorption of BAY 59-7939 (Rivaroxaban), an Oral, Direct Factor Xa Inhibitor, in Healthy Subjects.

Published in:

Journal of Clinical Pharmacology, 2006, v. 46, n. 5, p. 549, doi. 10.1177/0091270006286904

By:

Kubitza, Dagmar;
Becka, Michael;
Zuehlsdorf, Michael;
Mueck, Wolfgang

Publication type:

Article

Pharmacokinetics of Buspirone in Autistic Children.

Published in:

Journal of Clinical Pharmacology, 2006, v. 46, n. 5, p. 508, doi. 10.1177/0091270006286903

By:

Edwards, David J.;
Chugani, Diane C.;
Chugani, Harry T.;
Chehab, Jamal;
Malian, Monica;
Aranda, Jacob V.

Publication type:

Article

Clinical Evaluation of QT/QTc Prolongation and Proarrhythmic Potential for Nonantiarrhythmic Drugs: The International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use E14 Guideline.

Published in:

Journal of Clinical Pharmacology, 2006, v. 46, n. 5, p. 498, doi. 10.1177/0091270006286436

By:

Darpo, Borje;
Nebout, Thierry;
Sager, Philip T.

Publication type:

Article